A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
Clinical trial NCT03517722 · TERMINATED
Trial details
- NCT number
- NCT03517722
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2020-11-05
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.